Gunnar Ragnarsson Discusses Progress in Cellular Therapies and Challenges in Treating Solid Tumors at ESMO 2026 – JBMS
Gunnar Ragnarsson/JBMS/latimes.com

Gunnar Ragnarsson Discusses Progress in Cellular Therapies and Challenges in Treating Solid Tumors at ESMO 2026 – JBMS

Journal of Breakthroughs in Medicine and Science shared on LinkedIn:

“As part of the JBMS × LA Times Studios Doctors and Scientists interview series at ESMO 2026, we spoke with Gunnar Ragnarsson, MD, MSc, Medical Oncologist and Internist at the South Iceland Healthcare Institution (HSU).

The conversation covered emerging approaches in cancer immunotherapy, progress in cellular therapies, and the challenges that remain in treating solid tumors.

Dr. Ragnarsson also discussed the importance of learning from clinical trials, including results that do not meet expectations, to help improve future treatments.

Drawing on his experience in Iceland, he highlighted another important challenge: ensuring that advances in cancer care reach patients in remote communities through patient education, telemedicine, and stronger connections between local healthcare providers and specialist centers.

Watch the full interview: Gunnar Ragnarsson, MD, MSc, a medical oncologist, joins JBMS at ESMO 2026.”

“We tried to learn from each patient and learn how to improve therapy along the way.” – Gunnar Ragnarsson, MD

You can also read:

Lilit Iritsyan Announces the Launch of the Journal of Breakthroughs in Medicine and Science During ESMO Week.

Farhatullah Syed։ Could CAR T Cells Fight Solid Tumors Better by Taking Scheduled Breaks?

Aleix Prat: A Major Step Toward Bringing CAR-T Therapies to Solid Tumors.